Vyleesi Oakland, NJ
Introducing the first and only FDA-approved as-needed treatment for pre-menopausal women with acquired, generalized Hypoactive Sexual Desire Disorder (HSDD).
Women with HSDD have an imbalance of neurotransmitter activity in the brain that impacts sexual desire: too few excitatory signals (such as dopamine or melanocortins) or too many inhibitory signals (such as serotonin) or a combination of both.
How does Vyleesi do this?
Women who have HSDD have an imbalance of neurotransmitter (chemical messengers) activity in the brain, resulting in low sexual desire. Vyleesi is believed to act on certain neurotransmitters, called melanocortins, to help improve sexual desire.
So…is it effective?
We’ll let the science do the talking.
The Vyleesi clinical studies included more than 1,200 premenopausal women with HSDD.
Here’s what they’ve found:
Here are FOUR yes or no questions to help you identify if you have HSDD:
- In the past, was your level of sexual desire or interest good & satisfying to you?
- Has there been a decrease in your level of sexual desire or interest?
- Are you bothered by the decreased level of sexual desire or interest?
- Would you like your level of sexual desire or interest to increase?
Call us today or reach out to us online to schedule your consultation with our Nurse, Beth and receive your first month’s supply for FREE!